カテゴリ： GlobalData, アメリカ, 企業調査

Pharmaceutical Product Development LLC：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Pharmaceutical Product Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C3322
◆発行会社（調査会社）：GlobalData
◆発行日：2018年8月
◆ページ数：61
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Pharmaceutical Product Development LLC (PPD) is a contract research organization (CRO), which offers drug discovery, development and lifecycle management services. The company’s service portfolio encompasses early development clinical trial services, drug research and development, regulatory support and late-stage clinical trial management, among others. It has expertise in clinical trials in therapy areas including cardiovascular system, central nervous system, dermatology, gastroenterology, hematology, cancer, infectious diseases, ophthalmology, respiratory and endocrine systems, metabolism, rare diseases and urology. PPD’s clients include pharmaceutical, biotechnology, medical device, and academic and government organizations. The company has a presence in North America, South America, Europe, Middle East, Africa, and Asia-Pacific. PPD is headquartered in Wilmington, North Carolina, the US.

Pharmaceutical Product Development LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 10
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Pharmaceutical Product Development Acquires Sequential Parallel Comparison Design from RCT Logic 13
Partnerships 14
Pharma Product Development Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 14
BioDuro Enters into Agreement with Porton Pharma Solutions 15
Pharmaceutical Product Development Enters into Agreement with Quotient Sciences 16
Treos Bio Enters into Agreement with Pharmaceutical Product Development 17
Pharmaceutical Product Development Enters into Agreement with Frenova Renal Research 18
Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 19
Pharma Product Development Enters into Agreement with BARDA 20
Pharma Product Development Enters into Contract Agreement with USAMMDA and USAMRMC 21
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 22
BioAtla Enters into Co-Development Agreement with BioDuro 23
Boston Strategics Enters into Agreement with Molecular Response 24
Pharmaceutical Product Development and X-Chem Form Joint Venture 25
Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 26
Pharma Product Development Expands Co-Development Agreement With VirtualScopics 27
Debt Offering 28
Jaguar Holding Company II and Pharmaceutical Product Development to Raise USD1,125 Million in Private Placement of Notes 28
Pharmaceutical Product Development Announces Public Offering Of Notes For US$500 Million 29
Asset Transactions 30
Crown Bioscience Acquires PDX Business Unit from Molecular Response 30
Acquisition 31
LabCorp May Acquire Pharmaceutical Product Development 31
Pharmaceutical Product Development Acquires Evidera 32
BioDuro Acquires Formex 33
Pharmaceutical Product Development Exercises Option to Acquire Remaining 36% Stake in X-Chem 34
Pharmaceutical Product Development Acquires Acurian, Patient Recruitment Company 35
Pharmaceutical Product Development LLC – Key Competitors 36
Pharmaceutical Product Development LLC – Key Employees 37
Pharmaceutical Product Development LLC – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Joint Venture 41
Recent Developments 42
Strategy And Business Planning 42
Mar 28, 2018: PPD Expands GMP Biologics Testing Capacity 42
May 18, 2017: PPD Expands Vaccine Development Laboratory 43
Feb 28, 2017: PPD Introduces Rare Disease and Pediatric Center of Excellence 44
Jan 30, 2017: PPD to Open New Clinical Research Unit in Las Vegas 45
Corporate Communications 46
Jul 24, 2018: PPD Names Ron Garrow as Chief Human Resource Officer 46
May 04, 2018: Christopher Scully Joins PPD as Chief Financial Officer 47
Feb 01, 2018: Pharmaceutical Product Development Appoints Maria Teresa Hilado As Board Director 48
Jan 03, 2018: PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors 49
Government and Public Interest 50
Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 50
Feb 21, 2018: PPD Recognized for Superior Employee Development 52
Mar 02, 2017: PPD Awarded National Institutes of Health Contract for HIV Research Support 53
Product News 54
Jun 25, 2018: PPD’s PatientAdvantage Inverts Traditional Clinical Trial Delivery Method 54
Other Significant Developments 55
Jul 25, 2018: PPD Expands Central Labs’ Preclarus technology, helping clients accelerate and enhance clinical research decision making 55
Apr 23, 2018: Acurian and Synexus Launch NASH Patient Enrollment Solution 56
Feb 28, 2018: PPD and Acurian Introduce Innovative Patient Concierge Service for Clinical Trials 57
Oct 24, 2017: Evidera Expands Patient-Centered Research Services 58
May 08, 2017: PPD Creates Dedicated Real-world Research and Market Access Unit by Combining Medical Affairs Research Operations and Evidera 59
Mar 23, 2017: PPD Announces Industry-First Apprenticeship for Clinical Research Associates 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Key Facts 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharmaceutical Product Development LLC, Deals By Therapy Area, 2012 to YTD 2018 9
Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 10
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pharmaceutical Product Development Acquires Sequential Parallel Comparison Design from RCT Logic 13
Pharma Product Development Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 14
BioDuro Enters into Agreement with Porton Pharma Solutions 15
Pharmaceutical Product Development Enters into Agreement with Quotient Sciences 16
Treos Bio Enters into Agreement with Pharmaceutical Product Development 17
Pharmaceutical Product Development Enters into Agreement with Frenova Renal Research 18
Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 19
Pharma Product Development Enters into Agreement with BARDA 20
Pharma Product Development Enters into Contract Agreement with USAMMDA and USAMRMC 21
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 22
BioAtla Enters into Co-Development Agreement with BioDuro 23
Boston Strategics Enters into Agreement with Molecular Response 24
Pharmaceutical Product Development and X-Chem Form Joint Venture 25
Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 26
Pharma Product Development Expands Co-Development Agreement With VirtualScopics 27
Jaguar Holding Company II and Pharmaceutical Product Development to Raise USD1,125 Million in Private Placement of Notes 28
Pharmaceutical Product Development Announces Public Offering Of Notes For US$500 Million 29
Crown Bioscience Acquires PDX Business Unit from Molecular Response 30
LabCorp May Acquire Pharmaceutical Product Development 31
Pharmaceutical Product Development Acquires Evidera 32
BioDuro Acquires Formex 33
Pharmaceutical Product Development Exercises Option to Acquire Remaining 36% Stake in X-Chem 34
Pharmaceutical Product Development Acquires Acurian, Patient Recruitment Company 35
Pharmaceutical Product Development LLC, Key Competitors 36
Pharmaceutical Product Development LLC, Key Employees 37
Pharmaceutical Product Development LLC, Other Locations 38
Pharmaceutical Product Development LLC, Subsidiaries 40
Pharmaceutical Product Development LLC, Joint Venture 41

List of Figures
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Pharmaceutical Product Development LLC：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • ResApp Health Ltd (RAP)：製薬・医療：M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Southwestern Energy Co (SWN)：企業の財務・戦略的SWOT分析
    Southwestern Energy Co (SWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Saint-Gobain Ltd：企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Boston Scientific Corp (BSX)：企業の財務・戦略的SWOT分析
    Boston Scientific Corp (BSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Siltech Corp：企業の戦略的SWOT分析
    Siltech Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Isofol Medical AB (ISOFOL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • Decathlon S.A.：企業の戦略・SWOT・財務情報
    Decathlon S.A. - Strategy, SWOT and Corporate Finance Report Summary Decathlon S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Carter Holt Harvey Ltd：企業の戦略・SWOT・財務情報
    Carter Holt Harvey Ltd - Strategy, SWOT and Corporate Finance Report Summary Carter Holt Harvey Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Plantronics, Inc. (PLT)：企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Marina Biotech Inc (MRNA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Marina Biotech Inc (Marina) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …
  • Camlin Fine Sciences Limited：戦略・SWOT・企業財務分析
    Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Wolong Electric Group Co Ltd (600580)：電力：M&Aディール及び事業提携情報
    Summary Wolong Electric Group Co Ltd (Wolong) is a motor manufacturing company that manufactures and sells motor products and home appliances. The company’s products include motors and electronic-controlled devices, traction transformers, traction rectifier unit of UMT, UHV power transformers, elect …
  • Impellam Group plc (IPEL)：企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Thomas Cook Group plc (TCG)：企業の財務・戦略的SWOT分析
    Thomas Cook Group plc (TCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Exelixis Inc (EXEL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabomet …
  • Classic Cosmetics Inc：企業の戦略・SWOT・財務情報
    Classic Cosmetics Inc - Strategy, SWOT and Corporate Finance Report Summary Classic Cosmetics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China Health Group Inc (8225)：企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • SOLX Inc：医療機器：M&Aディール及び事業提携情報
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • Merck KGaA：企業のM&A・事業提携・投資動向
    Merck KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Extendicare Inc.：企業の戦略・SWOT・財務情報
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆